Characterisation of APOBEC3B-Mediated RNA editing in breast cancer cells reveals regulatory roles of NEAT1 and MALAT1 lncRNAs.
Loading...
Embargo End Date
ICR Authors
Authors
Zhang, C
Lu, Y-J
Wang, M
Chen, B
Xiong, F
Mitsopoulos, C
Rossanese, O
Li, X
Clarke, PA
Lu, Y-J
Wang, M
Chen, B
Xiong, F
Mitsopoulos, C
Rossanese, O
Li, X
Clarke, PA
Document Type
Journal Article
Date
2024-11-11
Date Accepted
2024-09-13
Abstract
RNA editing is a crucial post-transcriptional process that influences gene expression and increases the diversity of the proteome as a result of amino acid substitution. Recently, the APOBEC3 family has emerged as a significant player in this mechanism, with APOBEC3A (A3A) having prominent roles in base editing during immune and stress responses. APOBEC3B (A3B), another family member, has gained attention for its potential role in generating genomic DNA mutations in breast cancer. In this study, we coupled an inducible expression cell model with a novel methodology for identifying differential variants in RNA (DVRs) to map A3B-mediated RNA editing sites in a breast cancer cell model. Our findings indicate that A3B engages in selective RNA editing including targeting NEAT1 and MALAT1 long non-coding RNAs that are often highly expressed in tumour cells. Notably, the binding of these RNAs sequesters A3B and suppresses global A3B activity against RNA and DNA. Release of A3B from NEAT1/MALAT1 resulted in increased A3B activity at the expense of A3A activity suggesting a regulatory feedback loop between the two family members. This research substantially advances our understanding of A3B's role in RNA editing, its mechanistic underpinnings, and its potential relevance in the pathogenesis of breast cancer.
Citation
Oncogene, 2024, 43 (46), pp. 3366 - 3377
Source Title
Oncogene
Publisher
SPRINGERNATURE
ISSN
0950-9232
eISSN
1476-5594
Collections
Research Team
RNA Bio & Mol Therap